HBC Share Price Performance
Recent HBC News & Updates
No updates
Hofseth BioCare ASA Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 22, 2025
- Earnings per share (EPS)
- -0.31
- Gross Margin
- 27.04%
- Net Profit Margin
- -47.22%
- Debt/Equity Ratio
- 900.0%
Hofseth BioCare ASA Competitors
About HBC
- Founded
- 2000
- Employees
- 75
- CEO
- WebsiteView website
Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, rest of Europe, Japan, Asia, and the United States. The company offers ProGo, a bioactive peptide for weight management and metabolic health; OmeGo, a salmon oil that provides a full spectrum of fatty acids and omegas; CalGo and NT-II, which are calcium collagen complexes that support joint and bone health; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was founded in 2000 and is headquartered in Ålesund, Norway.
Norwegian Market Performance
- 7 Days: -0.4%
- 3 Months: 5.5%
- 1 Year: 6.9%
- Year to Date: 4.8%
The market has stayed flat over the 7 days. As for the longer term, the market has risen 6.9% in the past 12 months. As for the next few years, earnings are expected to grow by 11% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading